Six-Dose ciprofloxacin (CIP) is Equivalent to standard 10-dose therapy in children with shigella dysenteriae type 1 (SDI) Infection : results of a multicentre, randomized double-blind trial[abstract]
Full metadata record
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Khan, W.A. | - |
| dc.date.accessioned | 2009-11-05T05:25:56Z | - |
| dc.date.available | 2009-11-05T05:25:56Z | - |
| dc.date.issued | 2001-09 | - |
| dc.identifier.citation | In:41st Interscience Conference on Antimicrobial Agents and Chemotherapy Chicago, Illinois September 22-25, 2001:271p. | en |
| dc.identifier.uri | http://hdl.handle.net/123456789/2542 | - |
| dc.format.extent | 111421 bytes | - |
| dc.format.mimetype | application/pdf | - |
| dc.language.iso | en | en |
| dc.subject | Bangladesh | en |
| dc.subject | Ciprofloxacin | en |
| dc.subject | Double-blind method | en |
| dc.subject | Drug therapy | en |
| dc.subject | Drug therapy, Microbial | en |
| dc.subject | Multicenter studies | en |
| dc.subject | Shigella dysenteriae | en |
| dc.subject | Therapeutic use | en |
| dc.title | Six-Dose ciprofloxacin (CIP) is Equivalent to standard 10-dose therapy in children with shigella dysenteriae type 1 (SDI) Infection : results of a multicentre, randomized double-blind trial[abstract] | en |
| dc.type | Other | en |
| Appears in Collections: | C. Letters, editorials, and abstracts | |
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
| 2001-41stICAACAbstract-271-KhanWA.pdf | 108.81 kB | Adobe PDF | View/Open Request a copy |
This item is protected by original copyright |